DE HR34

Expresses legislative intent to phase out avoidable PFAS (per- and polyfluoroalkyl substances) in consumer products sold in Delaware, consistent with actions taken by other states

Cites health risks associated with PFAS including increased cholesterol, decreased birth weight, reduced vaccine effectiveness, kidney and testicular cancer, and pregnancy-related hypertension

Notes that Delaware taxpayers have spent an estimated $20 million remediating PFAS pollution and that the state has filed lawsuits against PFAS manufacturers to recoup cleanup costs

References that 15 states have already phased out or regulated PFAS in textiles, packaging, cosmetics, and cookware, and that 23 states use a comprehensive PFAS definition

Acknowledges Delaware's existing PFAS-related actions including proposed drinking water contamination levels and bans on PFAS use in firefighting foam training